Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation

Kidney and Blood Pressure Research

Volumn 34, Issue 2, 2011, Pages 97-103

  Henschkowski, Jana ^a,b   Bischoff Ferrari, Heike A ^a,b   Wüthrich, Rudolf P ^c   Serra, Andreas L ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Institute of Physical Medicine   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cinacalcet; Kidney; Meta analysis; Mimpara; Transplantation

Indexed keywords

CALCIUM; CINACALCET; CREATININE;

ARTICLE; CALCIUM BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERSISTENT HYPERPARATHYROIDISM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

CALCIUM; CREATININE; HUMANS; HYPERPARATHYROIDISM; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; NAPHTHALENES;

EID: 79151476865     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323902     Document Type: Article

References (28)

1. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF: Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998; 95: 4040-4045. (Pubitemid 28173250)
2. Brown EM, Hebert SC: Calcium-receptor-regulated parathyroid and renal function. Bone 1997; 20: 303-309. (Pubitemid 27196653)
3. Lobo PI, Cortez MS, Stevenson W, Pruett TL: Normocalcemic hyperparathyroidism associated with relatively low 1,25-vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant 1995; 9: 277-281.
4. Reinhardt W, Bartelworth H, Jockenhovel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K: Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998; 13: 436-442.
5. Julian BA, Quarles LD, Niemann KM: Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 1992; 19: 99-120.
6. Hernandez D, Rufino M, Bartolomei S, Gonzalez-Rinne A, Lorenzo V, Cobo M, Torres A: Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int 2005; 67: 2015-2020. (Pubitemid 40577740)
7. Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A: Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 2005; 5: 1934-1941. (Pubitemid 41039868)
8. Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H: Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 2007; 22: 584-591. (Pubitemid 46189905)
9. Block GA, Martin KJ, de Francisco AL, et al: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525. (Pubitemid 38477776)
10. Apostolou T, Damianou L, Kotsiev V, Drakopoulos S, Hadjiconstantinou V: Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Clin Nephrol 2006; 65: 374-377. (Pubitemid 43676425)
11. Apostolou T, Kollia K, Damianou L, Kaitsioti H, Kotsiev V, Dracopoulos S, Vougas V, Hadjiconstantinou V: Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet. Transplant Proc 2006; 38: 3514-3516. (Pubitemid 44908511)
12. El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA: Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 2007; 83: 546-549. (Pubitemid 46440240)
13. Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, Sridhar N, Blessios G, Venuto R, Pankewycz O: Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 2006; 6: 2391-2395. (Pubitemid 44359425)
14. Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wuthrich RP: Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 2007; 22: 577-583. (Pubitemid 46189904)
15. Serra AL, Schwarz AA, Wick FH, Marti HP, Wuthrich RP: Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315-1319. (Pubitemid 41430604)
16. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, Meier-Kriesche H-U: Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 323-326.
17. Szwarc I, Argiles A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G: Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006; 82: 675-680. (Pubitemid 44395239)
18. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG: The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311-1314. (Pubitemid 41435024)
19. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG: Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2007; 22: 2362-2365. (Pubitemid 47244719)
20. Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, Peacock M: Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94: 2766-2772.
21. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D: Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2005; 90: 135-141. (Pubitemid 40116646)
22. Serra AL, Braun SC, Starke A, Savoca R, Hersberger M, Russmann S, Corti N, Wuthrich RP: Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. Am J Transplant 2008; 8: 803-810. (Pubitemid 351347748)
23. Kamar N, Gennero I, Spataru L, Esposito L, Guitard J, Lavayssiere L, Cointault O, Gandia P, Durand D, Rostaing L: Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nephrol Dial Transplant 2008; 23: 3720-3726.
24. Borchhardt KA, Heinzl H, Mayerwoger E, Horl WH, Haas M, Sunder-Plassmann G: Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation 2008; 86: 919-924.
25. Bergua C, Torregrosa JV, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, Campistol JM: Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 2008; 86: 413-417.
26. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, Meier-Kriesche HU: Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 323-326.
27. Lopez V, Toledo R, Sola E, Gutierrez C, Sujan S, Rodriguez MA, Cabello M, Burgos D, Gonzalez Molina M, Hernandez D: Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. Transplant Proc 2009; 41: 2394-2395.
28. Chennuru S, Koduri J, Baumann MA: Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid. Intern Med J 2008; 38: 635-637.